Metabolic factors involved in the therapeutic response of patients with hepatitis C virus‐related chronic hepatitis

Abstract

Insulin-resistance syndrome could contribute to non-response in treated chronic HCV patients, suggesting the presence of dysmetabolic factors that frequently cluster in a critical combination.